Effects of sodium warfarin and other carcinostatic agents on malignant cells: a study of drug synergy.
D000818:Animals; D002250:Carbon Radioisotopes; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy / Q000473:pathology; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D046508:Culture Techniques; D004357:Drug Synergism; D005472:Fluorouracil / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005909:Glioblastoma / Q000188:drug therapy; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D007739:L Cells / Q000187:drug effects; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D008862:Microsomes, Liver / Q000187:drug effects; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009457:Neuroglia / Q000187:drug effects; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D012335:RNA, Ribosomal; D014859:Warfarin / Q000494:pharmacology / Q000627:therapeutic use*
D002250:Carbon Radioisotopes; D012335:RNA, Ribosomal; D014859:Warfarin; D005472:Fluorouracil